First National Bank Of Hutchinson Abb Vie Inc. Transaction History

First National Bank Of Hutchinson

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $106,872 - $123,720	-800 Reduced 23.53%	2,600 $387,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $315,394 - $363,223	-2,181 Reduced 39.08%	3,400 $541,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $25,034 - $30,022	181 Added 3.35%	5,581 $902,000
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $6,628 - $7,384	-63 Reduced 1.15%	5,400 $608,000
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $16,806 - $21,028	233 Added 4.46%	5,463 $483,000
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $155,700 - $192,020	2,000 Added 61.92%	5,230 $482,000
Q2 2018 Jul 12, 2018	SELL	$89.78 - $106.23 $8,978 - $10,623	-100 Reduced 3.0%	3,230 $299,000
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $9,201 - $12,321	100 Added 3.1%	3,330 $315,000
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $225,615 - $288,180	3,230	3,230 $290,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of First National Bank Of Hutchinson, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Hutchinson with notifications on news.